|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Acetylator phenotype in Behcet's disease显示文摘 | Najim RA Sharquie KE A1-Janabi MH | 2003 | Adv Exp Med Biol2003，30，6： | 1 |
| 2 | Inflammatory changes in vitiligo:stage Ⅰ and Ⅱ depigmentation显示文摘 | Sharquie KE Mehenna SH Naji AA | 2004 | Am J Dermatopathol2004，26，2： | 1 |
| 3 | Prevalence and patterns of neurological involvement in Behcet's disease:a prospective study from Iraq显示文摘 | Al-Araji A Sharquie K Al-Rawi Z | 2003 | J Neurol Neurosurg Psychiatry2003，74，5： | 1 |
| 4 | Keloid in Iraqi patients: a clinicohistopathologic study显示文摘 | Sharquie K E AI-Dhalimi M A | 2003 | Dermatol Surg2003，29，8： | 1 |
| 5 | Oral zinc sulphate in thetreatment of recalcitrant viral warts : randomized placebo -controlledclinical trial 显示文摘 | Al-Gurairi FT A1-Waiz M Sharquie KE | 2002 | Br J Dennatol2002，146，： | 1 |
| 6 | Lactic acid as a new therapeutic peeling agent in melasma显示文摘 | AL-TIKREETY M M AL-MASHHADANI S A | 2005 | Dermatol Surg2005，31，2： | 1 |
| 7 | 口服硫酸锌治疗酒渣鼻:一项双盲、安慰剂对照研究显示文摘Background: Rosacea is a skin problem not uncommonly encountered world-wide. There is a need for an effective and well-tolerated treatment for this disease. Objective: To evaluate the efficacy and side-effects of zinc sulfate in rosacea in a randomized, controlled, double-blind trial. Patients and methods: Patients with rosacea who attended the outpatient Clinic of Dermatology and Venereology in Baghdad Teaching Hospital were recruited into this study between October 2002 and August 2004. A disease severity score was calculated for each patient. The patients were randomly allocated to receive either zinc sulfate 100 mg or identical placebo capsules three times per day. Zinc sulfate and placebo capsules were given in a double blind manner. Following 3 months of starting the treatment, the patients crossed over, i.e. patients on placebo crossed over to zinc sulfate and those on zinc sulfate crossed over to placebo. Results: Twenty-five patients with rosacea were included in this study: 16 (64% ) females and nine (36% ) males. Nineteen patients completed the study: 11 (58% ) females and eight (42% ) males. Patient age ranged from 21 to 64 years with a mean ± SD of 48.2 ± 9.3 years. Duration of the disease ranged from 1 to 14 years with a mean ± SD of 4.4 ± 3.2 years. In the group started on zinc sulfate, the score before therapy ranged from 5 to 11 with a mean ± SD of 8 ± 2.0. The mean started to decrease directly after the first month of therapy with zinc sulfate to a significantly lower level. After shifting to placebo treatment, the mean started to rise gradually in the fifth month but remained significantly lower than the levels before therapy. In the group started on placebo, the score before therapy ranged from 5 to 9 with a mean ± SD of 7 ± 1.3. The mean remained high in the first 3 months of therapy while the patients were on placebo. After shifting to zinc sulfate, the mean started to decrease after the fourth month to significantly low levels. No important side-effects were reported apart from mild gastric upset in three (12% ) patients on zinc sulfate. Conclusion: Zinc sulfate was found to be a good option in the treatment of rosacea, as it was safe, effective and lacking important side-effects. | Sharquie K.E. Najim R.A Al-Salman H.N. 周少娜 | 2006 | 世界核心医学期刊文摘(皮肤病学分册)2006，2，9： | 1 |
| 8 | Prevalence and patterns of neurological involvement in Behcet's disease:a prospective study from Iraq显示文摘 | Al-Araji A Sharquie K Z Al-Rawi Z | 2003 | J Neurol Neurosurg Psychiatry2003，74，5： | 1 |
| 9 | Prevalence and patterns of neurological involvement in Behcet' s disease a prospective study from Iraq显示文摘 | Al-Araji A Sharquie K A1-Rawi Z | 2003 | J Neurol Neurosurg Psychiatry2003，74，： | 1 |
| 10 | Inflammatory changes inviti- ligo : stage I and 1I depigraentation 显示文摘 | Sharquie KE Mehenna SH Naji AA | 2004 | Am J Dermatopathol2004，26，2： | 1 |
| 11 | Inflammatory changes in vitiligo:stage I and II depigmentation显示文摘 | SHARQUIE K E MEHENNA S H NAJI A A | 2004 | Am J Dermatopathol2004，26，2： | 1 |
| 12 | Prevalence and patterns of neurological involvement in Behcet' s disease : a prospective study from Iraq显示文摘 | AL-Araji A Sharquie K Al-Rawi Z | 2003 | J Neurosurg Psychiatry2003，74，： | 1 |
| 13 | Melanocytes transplantation in patients with vitiligo using needling micrografting technique显示文摘 | Sharquie KE Noaimi AA A1-Mudaris HA | 2013 | J Drugs Dermatol2013，12，5： | 1 |
| 14 | Topical zinc sulphate solution for treatment of viral warts显示文摘 | Sharquie KE Khorsheed AA Al-Nuaimy AA | | 0，，09： | 1 |
| 15 | Lactic acid as a new thel'apeutic peeling agent in melasma显示文摘 | Sharquie KE A1-Tikreety MM A1-Mashhadani SA | 2005 | Dermatol Surg2005，31，2： | 1 |
| 16 | Prevalence and patterns of neurological involvement in Behcet' s disease : a prospective study from Iraq 显示文摘 | A1-Araji A Sharquie K A1-Rawi Z | 2003 | J Neurol Neurosurg Psychiatry2003，74，： | 1 |
| 17 | Onion Juice (Allium cepa L.), A New Topical Treatment for Alopecia Areata显示文摘 | Khalifa E. Sharquie Hala K. Al‐Obaidi | 2002 | The Journal of Dermatology2002，，6： | 1 |
| 18 | Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels显示文摘 | Sharquie KE Al-Tikreety MM A1-Mashhadani SA | 2006 | Dermatol Surg2006，32，12： | 1 |
| 19 | Inflammatory changes in vitiligo: stage I and II depigmentation显示文摘 | Sharquie KE Mehenna SH Naji AA | 2004 | Am J Dermatopathol2004，26，10： | 1 |
| 20 | Lactic Acid as anew therapeutic peeling agent in the treatment of lifa disease ( fric- tional dermal melanosis) 显示文摘 | Sharquie KE AI-Dhalimi MA Noaimi AA | 2012 | Indian J Dermatol2012，57，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员